Clinical Trial Update: A Study of Supaglutide in Chinese Type 2 Diabetes Patients [Phase 2]

View source ↗

Summary

Phase 2 trial of Supaglutide in Chinese patients with Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Supaglutide

Snippet

Sponsor: Shanghai Yinnuo Pharmaceutical Technology Co., Ltd. | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED